CDK12 is involved in tumorigenesis and is assigned oncogenic functions in, e.g., HER2-positive breast cancer, as well as tumor suppressor functions in, e.g., ovarian, prostate, and triple-negative breast cancer [44,45,47,50]. Here, ERBB2 is linked to triple-negative breast carcinoma.